Best Call Ever:They actually mentioned Revenue growth all year.
Competive bidding may not even be an issue in 2024.
Jan, Feb okay for Vents.
March and April great. It should be a nice 2nd quarter and year.
71% vent revenue, which is going down percentage wise, but revenue is going up which shows how diversified they are.
Bad debt expense should be normal or lower than last year.
Viemed is still buying shares.